Why Abzena?
Our focused approach.
The approach that we take to the challenge focuses on giving you insight to make informed decisions during your drug development journey.
Our experts develop phase-appropriate bioassays for assessment of potency, efficacy and safety, giving you the benefit of our experience across a diverse range of modalities.
In addition, we develop and comprehensively document the phase appropriate analytical methods necessary to produce high-quality, well-characterized material in combination with the rapid data needed to support successful IND and marketing applications.
To help understand your molecule in detail, we have an extensive panel of both target and effector cells together with a substantial in-house PBMC cell bank.
Complementing this is a broad choice of bioassay platforms, including:
GMP cell-based potency testing quantitively measures the biological activity of a bioconjugate drug. For Antibody-drug conjugates (ADCs), these critical assessments measure the cytotoxicity of the payload for both GMP product release and long-term stability testing. These important assays enable us to provide our customers with reliable data on their drug’s potency, which is essential for regulatory submissions.
By offering GMP cell-based potency assays alongside our robust suite of bioassay capabilities including developability, characterization, mechanism of action (MOA) studies, and immunogenicity, we can provide our customers with a more comprehensive, streamlined, and cost-effective way to access critical data even faster. Ultimately, allowing them to make data-driven decisions even sooner in their development journey.
Developed by our scientific experts to increase our biopharmaceuticals customers’ chances of clinical success and provide rapid data, LabZient™ is our next-generation analytical solution. To learn more, or access our latest LabZient™ info sheet, click the button below.
Our comprehensive bioassay solutions include both established assays and custom assay development matched to your individual program needs. Our bioassay services include the following:
Access is latest info sheet on our newly enhanced EpiScreen 2.0 platform to learn more.
We adapt our approach to shorten lead times and develop risk mitigations strategies to ensure your overall success in delivering vital medicines to patients.